BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35649600)

  • 41. Infection with Chlamydia trachomatis in female college students.
    McCormack WM; Rosner B; McComb DE; Evrard JR; Zinner SH
    Am J Epidemiol; 1985 Jan; 121(1):107-15. PubMed ID: 3964985
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of
    Lehtinen M; Lagheden C; Luostarinen T; Eriksson T; Apter D; Harjula K; Kuortti M; Natunen K; Palmroth J; Petäjä T; Pukkala E; Siitari-Mattila M; Struyf F; Nieminen P; Paavonen J; Dubin G; Dillner J
    BMJ Open; 2017 Aug; 7(8):e015867. PubMed ID: 28821519
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Y chromosome DNA in cervicovaginal self-collected samples of childbearing age women: Implications for epitheliotropic sexually transmitted infections?
    Silva J; Cerqueira F; Medeiros R
    Life Sci; 2015 Oct; 139():62-8. PubMed ID: 26281916
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of Chlamydia trachomatis in an asymptomatic female population attending cervical cytology services of three healthcare centers in Medellín, Colombia.
    Orozco-Hoyos N; Baena A; Montoya-Ruiz C; Sánchez GI; Restrepo E
    Biomedica; 2020 Sep; 40(3):534-545. PubMed ID: 33030832
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chlamydia trachomatis infection and persistence of human papillomavirus.
    Silins I; Ryd W; Strand A; Wadell G; Törnberg S; Hansson BG; Wang X; Arnheim L; Dahl V; Bremell D; Persson K; Dillner J; Rylander E
    Int J Cancer; 2005 Aug; 116(1):110-5. PubMed ID: 15756673
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of human papillomavirus and Chlamydia trachomatis infection among women attending cervical cancer screening in the Republic of Korea.
    Oh JK; Franceschi S; Kim BK; Kim JY; Ju YH; Hong EK; Chang YC; Rha SH; Kim HH; Kim JH; Kim CY; Shin HR
    Eur J Cancer Prev; 2009 Feb; 18(1):56-61. PubMed ID: 19077566
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae and human papillomavirus in a sexual health clinic setting in urban Sri Lanka.
    Samarawickrema NA; Tabrizi SN; Young E; Gunawardena P; Garland SM
    Int J STD AIDS; 2015 Sep; 26(10):733-9. PubMed ID: 25258396
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The risk of cervical atypia in oral contraceptive users.
    Adhikari I; Eriksson T; Luostarinen T; Lehtinen M; Apter D
    Eur J Contracept Reprod Health Care; 2018 Feb; 23(1):12-17. PubMed ID: 29412045
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human papillomavirus as an independent risk factor of invasive cervical and endometrial carcinomas in Jordan.
    Abu-Lubad MA; Jarajreh DA; Helaly GF; Alzoubi HM; Haddadin WJ; Dabobash MD; Albataineh EM; Aqel AA; Alnawaiseh NA
    J Infect Public Health; 2020 Apr; 13(4):613-618. PubMed ID: 31519382
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk factors for HPV DNA detection in middle-aged women.
    Muñoz N; Kato I; Bosch FX; Eluf-Neto J; De Sanjosé S; Ascunce N; Gili M; Izarzugaza I; Viladiu P; Tormo MJ; Moreo P; Gonzalez LC; Tafur L; Walboomers JM; Shah KV
    Sex Transm Dis; 1996; 23(6):504-10. PubMed ID: 8946637
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents.
    Samoff E; Koumans EH; Markowitz LE; Sternberg M; Sawyer MK; Swan D; Papp JR; Black CM; Unger ER
    Am J Epidemiol; 2005 Oct; 162(7):668-75. PubMed ID: 16120706
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human papillomavirus and Chlamydia trachomatis infections in adolescents and young women: Prevalence and risk factors.
    Ribeiro AA; Saddi VA; Carneiro MA; Figueiredo-Alves RR; da Silva Barros NK; de Almeida Carvalho KP; do Nascimento Tavares SB; de Araújo Teles S; D'Alessandro WB; Rabelo-Santos SH
    Diagn Cytopathol; 2020 Aug; 48(8):736-744. PubMed ID: 32379403
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association between visual inspection of the cervix with acetic acid examination and high-risk human papillomavirus infection, Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis in Papua New Guinea.
    Vallely AJ; Toliman PJ; Ryan C; Rai G; Wapling J; Gabuzzi J; Kumbia A; Kombuk B; Kombati Z; Vallely LM; Kelly-Hanku A; Wand H; Tabrizi SN; Mola GDL; Kaldor JM
    Aust N Z J Obstet Gynaecol; 2018 Oct; 58(5):576-581. PubMed ID: 29380356
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular characterization of lower vaginal swabs for Human papilloma virus in association with Chlamydia trachomatis infection in Cameroonian Women.
    Fogue P; Djeudong G; Bouting G; Aglago E; Simo G; Lueong S
    J Infect Public Health; 2018; 11(3):314-320. PubMed ID: 28919017
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk Factors for Incident and Redetected Chlamydia trachomatis Infection in Women: Results of a Population-Based Cohort Study.
    Harder E; Thomsen LT; Frederiksen K; Munk C; Iftner T; van den Brule A; Kjaer SK
    Sex Transm Dis; 2016 Feb; 43(2):113-9. PubMed ID: 26760181
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chlamydia trachomatis detection in cervical PreservCyt specimens from an Irish urban female population.
    Keegan H; Ryan F; Malkin A; Griffin M; Lambkin H
    Cytopathology; 2009 Apr; 20(2):111-6. PubMed ID: 18093220
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chlamydia trachomatis, Neisseria gonorrhoeae and human papillomavirus infections of lower genital tract of Indigenous women from Xingu Indigenous Park.
    Correa Porto CRC; Longatto-Filho A; De Almeida BC; Bonetti TC; Kamaiurá SFA; Diaz RS; Heinke T; Cury FP; Santana IVV; Queiroz MM; Rodrigues DA; De Gois Speck NM
    Rural Remote Health; 2023 Jul; 23(3):7126. PubMed ID: 37516453
    [TBL] [Abstract][Full Text] [Related]  

  • 58. National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study.
    Smith MA; Sherrah M; Sultana F; Castle PE; Arbyn M; Gertig D; Caruana M; Wrede CD; Saville M; Canfell K
    BMJ; 2022 Mar; 376():e068582. PubMed ID: 35354610
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial.
    Roset Bahmanyar E; Paavonen J; Naud P; Salmerón J; Chow SN; Apter D; Kitchener H; Castellsagué X; Teixeira JC; Skinner SR; Jaisamrarn U; Limson GA; Garland SM; Szarewski A; Romanowski B; Aoki F; Schwarz TF; Poppe WA; De Carvalho NS; Harper DM; Bosch FX; Raillard A; Descamps D; Struyf F; Lehtinen M; Dubin G;
    Gynecol Oncol; 2012 Dec; 127(3):440-50. PubMed ID: 22940493
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genital tract infection with Chlamydia trachomatis in women attended at a cervical cancer screening program in Northeastern from Brazil.
    Magalhães PA; Miranda CA; Lima ÉG; Moizéis RN; de Lima DB; Cobucci RN; de Medeiros Fernandes TA; de Azevedo JC; de Azevedo PR; de Araújo JM; Fernandes JV
    Arch Gynecol Obstet; 2015 May; 291(5):1095-102. PubMed ID: 25326872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.